AI Signal Dashboard
Last updated: 04.13 17:02
Top Undervalued
+1.7¢
55M+(Yes)
+0.5¢
<45M(Yes)
+0.5¢
50M–55M(Yes)
Encore Medical IPO Closing Market Cap AI analysis: • +1.7¢ undervalued • Live Prediction Market fair value & mispricing alerts.
Undervalued Options Insights:
Official filings indicate Encore Medical plans an IPO at $5 per share, targeting a ~$49M market cap....
🔓 Unlock Mispricing Insights (Pro)
Real-time High Yield Opportunities
View MoreAll
Outcomes
Market
Price
AI Fair
Value
Value
Edge
55M+
YesNo
2.35¢
97.65¢
4¢
96¢
+1.7¢
0¢
<45M
YesNo
39.5¢
60.5¢
40¢
60¢
+0.5¢
0¢
Expand to view all 5 options
⚠️ Risk Warning: Live data may lag! Prices can shift instantly due to news or low liquidity. Before trading, use AI Chat for [Live Recalculate], [Check Liquidity], [Trollbox Radar], or review [Fair Value Logic] to verify.
Divergence
There is a significant divergence. Official filings and mainstream financial media (e.g., Renaissance Capital) report that Encore Medical's proposed IPO price of $5 implies an initial market cap of $49 million, which falls squarely into the '45M–50M' bracket. However, the prediction market assigns only a 12.5% probability to this range, overwhelmingly betting on either a delay ('No IPO', 35.5%) or a broken IPO ('<45M', 39.5%). This highlights a deep distrust among traders regarding the company's ability to successfully list and sustain its target valuation.